Recent Finacing
Recent Raise
Acousia Therapeutics is a Tübingen-based clinical-stage biotech developing Kv7.4-activating small molecules, including ACOU085 delivered via transtympanic slow-release gel, to protect, restore, and enhance cochlear hair-cell function.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
